verapamil has been researched along with sirolimus in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
| Cuddon, P; Fleming, A; Floto, RA; Goldsmith, P; Jahreiss, L; O'Kane, CJ; Pask, D; Rubinsztein, DC; Saiki, S; Sarkar, S; Siddiqi, FH; Ttofi, EK; Williams, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lay, RH; Medh, RD; Schmidt, TJ | 1 |
| Crowe, A; Lemaire, M | 1 |
| Kato, K; Li, ST; Mikoshiba, K | 1 |
| Allison, MJ; Beyer, D; Bizot, MN; Jiang, Q; Kovarik, JM; Schmouder, RL | 1 |
| Anglicheau, D; Beaune, P; Cassinat, B; Legendre, C; Marquet, P; Méria, P; Pallet, N; Rabant, M; Thervet, E | 1 |
| Ambudkar, SV; Calcagno, AM; Gottesman, MM; Kim, IW; Kimchi-Sarfaty, C; Oh, JM; Sauna, ZE | 1 |
| Heimberg, H; Ling, Z; Pipeleers, D; Wang, Q | 1 |
| Rund, D | 1 |
| Campesi, I; Capobianco, G; Dessole, S; Fois, M; Franconi, F; Montella, A; Occhioni, S | 1 |
1 review(s) available for verapamil and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for verapamil and sirolimus
| Article | Year |
|---|---|
Pharmacokinetic interaction between verapamil and everolimus in healthy subjects.
Topics: Analysis of Variance; Calcium Channel Agonists; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Everolimus; Humans; Immunosuppressive Agents; Sirolimus; Verapamil | 2005 |
13 other study(ies) available for verapamil and sirolimus
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imidazoline Receptors; Minoxidil; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Type C Phospholipases; Verapamil | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.
Topics: Animals; Corticosterone; Cortodoxone; Cyclosporine; Desoxycorticosterone; Dexamethasone; Genes, Reporter; Glucocorticoids; Hydrocortisone; Immunosuppressive Agents; L Cells; Luciferases; Mice; Polyenes; Quinidine; Receptors, Glucocorticoid; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Transcription, Genetic; Transfection; Triamcinolone Acetonide; Verapamil | 1998 |
In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.
Topics: Animals; Caco-2 Cells; Everolimus; Humans; Immunosuppressive Agents; Intestinal Absorption; Mannitol; Propranolol; Rats; Rats, Wistar; Sirolimus; Verapamil | 1998 |
High Ca(2+)/low Mg(2+) solution induces long-term depression in rat CA1 pyramidal neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Benzoates; Calcium; Calcium Channel Blockers; Electric Stimulation; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; In Vitro Techniques; Magnesium; Neuronal Plasticity; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Sirolimus; Solutions; Tacrolimus; Verapamil | 2000 |
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction.
Topics: Acetanilides; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Culture Techniques; Cell Survival; Cells, Cultured; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Drug Interactions; Epithelial Cells; Fluorescent Dyes; Humans; Immunosuppressive Agents; Kidney; Pyrroles; Quinine; Quinolines; Rhodamines; Sirolimus; Verapamil | 2006 |
A "silent" polymorphism in the MDR1 gene changes substrate specificity.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Membrane; Chlorocebus aethiops; Codon; Cyclosporine; Genes, MDR; Haplotypes; HeLa Cells; Humans; Mutagenesis, Site-Directed; Polymorphism, Single Nucleotide; Protein Biosynthesis; Protein Conformation; Protein Folding; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; RNA, Messenger; Sirolimus; Substrate Specificity; Transfection; Verapamil | 2007 |
Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Glyburide; Hypoglycemic Agents; Immunosuppressive Agents; Insulin-Secreting Cells; Male; Mitogen-Activated Protein Kinases; Protein Biosynthesis; Rats; Rats, Wistar; Sirolimus; Transcription Factors; Verapamil | 2008 |
'Rapping' on the door of drug resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Cricetinae; Cricetulus; Drug Resistance, Neoplasm; Humans; Macrolides; Neoplasms; Sirolimus; Verapamil | 2009 |
Sex-specific pharmacological modulation of autophagic process in human umbilical artery smooth muscle cells.
Topics: Autophagy; Beclin-1; Cells, Cultured; Female; Humans; Infant, Newborn; Male; Microtubule-Associated Proteins; Myocytes, Smooth Muscle; Sex Characteristics; Sirolimus; TOR Serine-Threonine Kinases; Umbilical Arteries; Verapamil | 2016 |